Race, APOL1 Risk, and eGFR Decline in the General Population.
about
APOL1 Risk Alleles are Associated with More Severe Arteriosclerosis in Renal Resistance Vessels with Aging and Hypertension.Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter.Research Needs to Improve Hypertension Treatment and Control in African Americans.APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension).APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults.Sickle Cell Trait and the Risk of ESRD in Blacks.Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial.APOL1 Genotype and Renal Function of Black Living Donors.APOL1 and Cardiovascular Disease: A Story in Evolution.Association Between APOL1 Genotypes and Risk of Cardiovascular Disease in MESA (Multi-Ethnic Study of Atherosclerosis).ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death.High-Density Lipoprotein in Chronic Kidney Diseases-The Devil Is in the Detail.Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKDRole of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition
P2860
Q37234093-A81E0BDF-3E38-48CE-AF98-38EDC9082704Q38967358-993B33BF-1677-483C-8007-DF578734A46DQ39112267-9616EA17-0D3B-44F3-B3BB-11CB519B6A07Q39589011-81246FC2-CF20-44E3-B70A-4598FB65EF19Q40177005-8D2F2D1B-F3CB-4B22-9A29-802B1609A1CFQ40184938-8BAB36D1-8CC2-44F9-A019-057855D714ABQ40298866-0855B768-A4ED-4F6D-B876-C78CA1A48648Q40733337-DF0ED43F-7108-4228-9DDB-4704ABE3893EQ41129046-052A1FC4-2029-4DA4-8199-AFFF1DBD43A5Q47562461-A7A3879A-4FA5-4892-BFC6-761EACA4987DQ47789682-2ADB7337-1E7A-4CEA-947C-0DF2CC3552ACQ49189649-30085820-AC46-4FF8-A4D3-9C38519B2020Q49215238-1E684946-A611-43EA-9079-EB51420C1119Q49409572-3A6F2BE3-629B-4213-856A-83B0A458D70DQ52374541-AD1798E3-26DB-4D5B-91D6-6706C56B6110Q52568967-99732068-A2EE-4FE9-B3AC-DA78150724B3Q57785854-21910E87-4150-4253-8B94-66300113B76AQ58701139-B7D3C135-AC8F-4143-AEC2-83B681513DC8
P2860
Race, APOL1 Risk, and eGFR Decline in the General Population.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Race, APOL1 Risk, and eGFR Decline in the General Population.
@en
type
label
Race, APOL1 Risk, and eGFR Decline in the General Population.
@en
prefLabel
Race, APOL1 Risk, and eGFR Decline in the General Population.
@en
P2093
P2860
P356
P1476
Race, APOL1 Risk, and eGFR Decline in the General Population.
@en
P2093
Adrienne Tin
Andreea M Rawlings
Casey M Rebholz
Lawrence J Appel
Michelle M Estrella
Morgan E Grams
P2860
P304
P356
10.1681/ASN.2015070763
P577
2016-03-10T00:00:00Z